CH CRL (R4)
0.9.0 - Draft

This page is part of the CH CRL (R4) (v0.9.0: STU Draft) based on FHIR R4. . For a full list of available versions, see the Directory of published versions

CodeSystem: NKRS - Type of Recurrence/Transformation

Summary

Defining URL:http://fhir.ch/ig/ch-crl/CodeSystem/nkrs-typerecurrencetransformation
Version:0.9.0
Name:NkrsTypeRecurrenceTransformation
Title:NKRS - Type of Recurrence/Transformation
Status:Active as of 2022-02-04 02:14:21+0100
Definition:

The data item records the type of first recurrence of the disease or the occurrence of a transformation.

Type of recurrence(s)/transformation(s) (Variable number: 8.1) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

Publisher:Bundesamt für Gesundheit BAG
Copyright:

CC-BY-SA-4.0

Content:Complete: All the concepts defined by the code system are included in the code system resource
Value Set:http://fhir.ch/ig/ch-crl/ValueSet/nkrs-typerecurrencetransformation ( is the value set for all codes in this code system)
Source Resource:XML / JSON / Turtle

This Code system is referenced in the content logical definition of the following value sets:

This code system http://fhir.ch/ig/ch-crl/CodeSystem/nkrs-typerecurrencetransformation defines the following codes:

CodeDisplayDefinition
1 ProgressionLocoregional new findings without disease free intermission. For example: the tumour that is still present starts to progress after a period of stabilisation.
2 TransformationThe development of one ICD-O M term into another (for example, the change of a haematopoetic or lymphoid neoplasm from chronic to acute phase). In order to decide on haematological transformation event, adherence to the ENCR recommendation and Haemacare guideline, cited below, is mandatory.
3 MetastasisNew finding at a site distant to the primary tumour, i.e. metachronous metastasis. Either with or without disease free intermission.
4 RelapseLocoregional new findings after a period of documented disease-free intermission or remission without detectable tumour.